Abstract:An analysis of 32 hospitalized infants and children from whom rhinoviruses were isolated in our diagnostic laboratories in 1982-83 suggests that these agents are associated with lower respiratory tract disease with focal findings in susceptible patients. In 23 cases, an acute lower respiratory disease was the cause for admission, while nine patients were cultured after new respiratory symptoms developed during hospitalization. Presenting signs and symptoms included cough (23), fever (19), rhinorrhea (19), resp… Show more
“…In earlier studies, group A RVs were also detected less frequently than group B RVs (1,2,24,26,32). Although at present, a higher number of group B RVs is known than group A RVs, analysis of epidemiological data indicated that group B RVs produced more than twice as many clinical infections per serotype as group A RVs did.…”
Section: Discussionmentioning
confidence: 75%
“…However, they may also be associated with more-severe lower respiratory tract infections in children, in the elderly (23,24,30,33), and in immunocompromised patients (14,39,48,49). RVs have been isolated from cases of cystic fibrosis (44), otitis media (3), sinusitis (37), and exacerbations of chronic bronchitis and asthma (12,21,22,34).…”
“…In earlier studies, group A RVs were also detected less frequently than group B RVs (1,2,24,26,32). Although at present, a higher number of group B RVs is known than group A RVs, analysis of epidemiological data indicated that group B RVs produced more than twice as many clinical infections per serotype as group A RVs did.…”
Section: Discussionmentioning
confidence: 75%
“…However, they may also be associated with more-severe lower respiratory tract infections in children, in the elderly (23,24,30,33), and in immunocompromised patients (14,39,48,49). RVs have been isolated from cases of cystic fibrosis (44), otitis media (3), sinusitis (37), and exacerbations of chronic bronchitis and asthma (12,21,22,34).…”
“…Despite a careful search for rhinovirus and enterovirus isolation data, no references were found in the literature to the isolation of either EV68 or HRV87 from clinical specimens after their first appearance and characterization. Serotyping of rhinovirus isolates is laborious and has been carried out in only a few studies (6,14,16,18). However, the typing of enteroviruses has been widespread and has resulted in lengthy reports of clinical enterovirus findings.…”
It has recently been reported that all but one of the 102 known serotypes of the genus Rhinovirus segregate into two genetic clusters (C. Savolainen, S. Blomqvist, M. N. Mulders, and T. Hovi, J. Gen. Virol. 83:333-340, 2002). The only exception is human rhinovirus 87 (HRV87). Here we demonstrate that HRV87 is genetically and antigenically highly similar to enterovirus 68 (EV68) and is related to EV70, the other member of human enterovirus group D. The partial nucleotide sequences of the 5 untranslated region, capsid regions VP4/VP2 and VP1, and the 3D RNA polymerase gene of the HRV87 prototype strain F02-3607 Corn showed 97.3, 97.8, 95.2, and 95.9% identity to the corresponding regions of EV68 prototype strain Fermon. The amino acid identities were 100 and 98.1% for the products of the two capsid regions and 97.9% for 3D RNA polymerase. Antigenic cross-reaction between HRV87 and EV68 was indicated by microneutralization with monotypic antisera. Phylogenetic analysis showed definite clustering of HRV87 and EV68 with EV70 for all sequences examined. Both HRV87 and EV68 were shown to be acid sensitive by two different assays, while EV70 was acid resistant, which is typical of enteroviruses. The cytopathic effect induced by HRV87 or EV68 was inhibited by monoclonal antibodies to the decay-accelerating factor known to be the receptor of EV70. We conclude that HRV87 and EV68 are strains of the same picornavirus serotype presenting features of both rhinoviruses and enteroviruses.
“…HRVs have been found to replicate effectively in lower airways and have been recovered from bronchoalveolar lavage fluids and bronchial biopsy samples (13,19,22,27,28). These viruses have been implicated as causes of asthma exacerbations (9,25) and severe respiratory tract illnesses in children, the immunosuppressed, and the elderly (3,5,7,21,29).…”
Increasing recognition of the association of rhinovirus with severe lower respiratory tract illnesses has clarified the need to understand the relationship between specific serotypes of rhinovirus and their clinical consequences. To accomplish this, a specific and sensitive assay to detect and serotype rhinovirus directly from clinical specimens is needed. Traditional methods of serotyping using culture and serum neutralization are time-consuming, limited to certain reference laboratories, and complicated by the existence of over 100 serotypes of human rhinoviruses (HRVs). Accordingly, we have developed a sequence-based assay that targets a 390-bp fragment accounting for approximately two-thirds of the 5 noncoding region (NCR). Our goal was to develop an assay permitting amplification of target sequences directly from clinical specimens and distinction among all 101 prototype strains of rhinoviruses. We determined the sequences of all 101 prototype strains of HRV in this region to enable differentiation of virus genotypes in both viral isolates and clinical specimens. We evaluated this assay in a total of 101 clinical viral isolates and 24 clinical specimens and compared our findings to genotyping results using a different region of the HRV genome (the VP4-VP2 region). Five specimens associated with severe respiratory disease in children did not correlate with any known serotype of rhinovirus and were found to belong to a novel genogroup of rhinovirus, genogroup C. Isolates were also found that corresponded to the genogroup A2 variant identified in New York and Australia and two other novel group A clusters (GAC1 and GAC2).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.